Advertisement
MTD vs SYK
Which Stock Would AI Choose? Mettler-Toledo International (MTD) vs. Stryker (SYK) Stock Comparison
Key Takeaways
- MTD has shown relative outperformance in recent market activity compared to broader indices, while SYK has faced headwinds including removal from major growth indexes.
- Both companies are scheduled to report second-quarter 2026 earnings around July 30, providing near-term catalysts for price discovery.
- MTD operates in precision instruments with exposure to laboratory and industrial markets, whereas SYK focuses on medical technology across orthopedics and surgical segments.
- Analyst consensus ratings remain constructive for both, with average price targets implying potential upside from recent trading levels.
- SYK maintains a dividend growth track record, including a recent increase, while MTD does not pay a dividend.
- Relative momentum favors MTD in the most recent two-week period amid broader sector rotation considerations.
Introduction
This comparison examines MTD and SYK to highlight differences in business models, recent stock behavior, and market positioning. Investors and traders seeking exposure to precision instrumentation or medical technology sectors may find the analysis relevant for assessing relative value and momentum in the current environment. The review draws on observable performance metrics and sector dynamics without forward projections.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. provides precision instruments and services for laboratory, industrial, and food retail applications. In recent weeks, MTD shares have traded in a range reflecting broader market volatility, with notable outperformance versus major indices over the most recent two-week period. Sentiment has been influenced by anticipation surrounding the upcoming second-quarter 2026 earnings release scheduled after market close on July 30. Analyst coverage remains supportive, with consensus targets reflecting measured optimism tied to operational execution in core weighing and analytical technologies.
SYK Overview and Recent Performance
Stryker Corporation develops medical technologies and services spanning orthopedics, medical and surgical equipment, and neurotechnology. Recent market activity for SYK has been shaped by its removal from several Russell growth indexes in late June and lingering effects from a prior cybersecurity incident. Shares have exhibited mixed price behavior amid these factors, with attention now directed toward the second-quarter 2026 results expected on July 30. The company recently increased its quarterly dividend, underscoring a commitment to shareholder returns within the healthcare equipment space.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the most suitable AI trading bots from hundreds available that trade thousands of different tickers. Only those demonstrating strong alignment with prevailing market conditions earn placement in this section. Available bots feature varied trading styles, strategies, timeframes, and performance statistics, with reported ranges including annualized returns up to +241%, win rates of 70–80%, and profit factors reaching 2.5–3.0 or higher across sectors such as semiconductors and energy. These tools enable users to review detailed metrics and select bots matching specific objectives. Explore the curated selection on the Trending AI Robots page for additional insights.
Head-to-Head Comparison
MTD and SYK differ fundamentally in sector exposure: MTD serves laboratory and industrial customers with high-margin precision equipment, while SYK participates in the more regulated medical device arena with recurring procedure-driven demand. Recent momentum has favored MTD on a short-term basis, contrasting with SYK’s index-related adjustments and operational disruptions. Risk profiles reflect MTD’s sensitivity to capital spending cycles versus SYK’s exposure to healthcare reimbursement and regulatory developments. Market sentiment for both remains tied to earnings visibility, with SYK offering dividend support absent in MTD.
Tickeron AI Verdict
Based on observable trend consistency and relative positioning in recent market activity, Tickeron’s AI would currently assign a higher probabilistic preference to MTD due to stronger short-term momentum indicators and fewer immediate structural headwinds compared with SYK. This assessment remains probabilistic and subject to updates from forthcoming earnings data and broader market shifts.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a Buy and SYK is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTD’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 1 green FA rating(s).
- MTD’s FA Score: 1 green, 4 red.
- SYK’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MTD’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 6 bullish TA indicator(s).
- MTD’s TA Score: 5 bullish, 4 bearish.
- SYK’s TA Score: 6 bullish, 4 bearish.
Price Growth
MTD (@Medical Specialties) experienced а -0.94% price change this week, while SYK (@Medical/Nursing Services) price change was +0.99% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.81%. For the same industry, the average monthly price growth was +11.88%, and the average quarterly price growth was +7.07%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.20%. For the same industry, the average monthly price growth was -0.54%, and the average quarterly price growth was -16.57%.
Reported Earning Dates
MTD is expected to report earnings on Jul 30, 2026.
SYK is expected to report earnings on Jul 30, 2026.
Industries' Descriptions
@Medical Specialties (-0.81% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-1.20% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| MTD | SYK | MTD / SYK | |
| Capitalization | 26.2B | 126B | 21% |
| EBITDA | 1.25B | 6.44B | 19% |
| Gain YTD | -7.031 | -5.666 | 124% |
| P/E Ratio | 30.45 | 38.17 | 80% |
| Revenue | 4.09B | 25.3B | 16% |
| Total Cash | 60.6M | N/A | - |
| Total Debt | 2.23B | 14.7B | 15% |
MTD | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 59 | |
SMR RATING 1..100 | 2 | 57 | |
PRICE GROWTH RATING 1..100 | 50 | 57 | |
P/E GROWTH RATING 1..100 | 52 | 80 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (10) in the Medical Specialties industry is significantly better than the same rating for MTD (99). This means that SYK’s stock grew significantly faster than MTD’s over the last 12 months.
SYK's Profit vs Risk Rating (59) in the Medical Specialties industry is somewhat better than the same rating for MTD (100). This means that SYK’s stock grew somewhat faster than MTD’s over the last 12 months.
MTD's SMR Rating (2) in the Medical Specialties industry is somewhat better than the same rating for SYK (57). This means that MTD’s stock grew somewhat faster than SYK’s over the last 12 months.
MTD's Price Growth Rating (50) in the Medical Specialties industry is in the same range as SYK (57). This means that MTD’s stock grew similarly to SYK’s over the last 12 months.
MTD's P/E Growth Rating (52) in the Medical Specialties industry is in the same range as SYK (80). This means that MTD’s stock grew similarly to SYK’s over the last 12 months.
| MTD | SYK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 65% | 3 days ago 54% |
| Stochastic ODDS (%) | 3 days ago 56% | 3 days ago 51% |
| Momentum ODDS (%) | 3 days ago 69% | 3 days ago 55% |
| MACD ODDS (%) | N/A | 4 days ago 49% |
| TrendWeek ODDS (%) | 3 days ago 64% | 3 days ago 54% |
| TrendMonth ODDS (%) | 3 days ago 58% | 3 days ago 47% |
| Advances ODDS (%) | 3 days ago 60% | 3 days ago 56% |
| Declines ODDS (%) | 26 days ago 65% | 12 days ago 53% |
| BollingerBands ODDS (%) | 3 days ago 71% | 3 days ago 47% |
| Aroon ODDS (%) | 3 days ago 54% | 3 days ago 45% |
Advertisement
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | +0.63% | ||
| A - MTD | 71% Closely correlated | +0.52% | ||
| TMO - MTD | 67% Closely correlated | +0.45% | ||
| BRKR - MTD | 67% Closely correlated | -0.86% | ||
| DHR - MTD | 64% Loosely correlated | +1.57% | ||
| AZTA - MTD | 61% Loosely correlated | -0.24% | ||
More | ||||
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.